sensitivity specificity

Related by string. Sensitivity specificity * SENSITIVITY . Sensitivity : sensitivity genetic variation . Overall External Sensitivity . heightened sensitivity . improves insulin sensitivity . Sensitivity analyzes . Sensitivity Risk chapter / Specificity : specificity AVEO believes . substrate specificity . reciprocal specificity . numerical specificity . receptor specificity * *

Related by context. Frequent words. (Click for all words.) 68 serum PSA 64 PCR assay 64 erythrocyte sedimentation rate 64 biochemical recurrence 63 univariate 63 platelet reactivity 63 FDG PET 63 lymph node metastasis 63 D dimer 63 immunohistochemical 63 Prognostic 62 myocardial perfusion 62 quantitative PCR 62 prognostic significance 62 qRT PCR 61 histopathological 61 immunostaining 61 quantitation 61 glomerular filtration rate 61 HBsAg 61 μmol L 61 serologic 61 multivariate analyzes 61 univariate analysis 60 OGTT 60 logistic regression 60 biodistribution 60 malignant lesions 60 carotid stenosis 60 histopathologic 60 creatinine levels 60 serum concentrations 60 Kaplan Meier 59 NMP# 59 cystatin C 59 nomogram 59 International Prostate Symptom 59 metabolic parameters 59 Preoperative 59 molecular biomarkers 59 CK MB 59 QTc prolongation 59 Prostate Specific Antigen 59 thyroid stimulating hormone 59 serum albumin 59 rheumatoid factor 59 Response Evaluation Criteria 59 virologic response 59 histologic 59 MR spectroscopy 59 advanced adenomas 59 tirofiban 58 reproducibility 58 HbA1C 58 Bioavailability 58 LC-MS/MS 58 serum calcium 58 pg ml 58 antigen PSA 58 μg L 58 immunoreactivity 58 % CI #.#-#.# [003] 58 P = .# 58 colorimetric 58 lymphadenectomy 58 linkage disequilibrium 58 genotypic 58 estrogen receptor ER 58 electrocardiographic 57 gene amplification 57 biopsy specimens 57 distant metastasis 57 Secondary endpoints included 57 serum testosterone 57 sustained virologic response 57 allelic 57 Recurrence Score 57 prospectively defined 57 KRAS mutations 57 PCR amplification 57 pharmacodynamic effects 57 p = .# [002] 57 prognostic 57 Secondary endpoints include 57 creatinine clearance 57 PCa 57 Arch Intern Med 57 Specificity 57 analgesic efficacy 57 Computed tomography 57 NGAL 57 estimated glomerular filtration 57 C Reactive Protein 57 apolipoprotein B 57 HbA 1c 57 poor metabolizers 57 echocardiographic 57 NT proBNP 57 biochemical markers 57 clinically meaningful improvement 56 covariance

Back to home page